| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human RTF2 recombinant protein (Position: D4-F306) was used as the immunogen for the RTF2 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
RTF2 Antibody / Replication termination factor 2 is a anti-RTF2 Rabbit antibody Polyclonal (rabbit origin) supplied in Lyophilized format. Recommended for workflows such as ELISA, Flow cytometry (FACS), Immunoprecipitation (IP), Immunofluorescence (IF), Immunocytochemistry (ICC), Western blot (WB) with listed reactivity in Human.
Key elements and design rationale
- Target: RTF2
- Antibody details: Rabbit, Polyclonal (rabbit origin), isotype Rabbit IgG
- Format: Lyophilized
- Applications (as listed): ELISA, FACS, IP, IF, ICC, WB
Biological background
Replication termination factor 2 associates with replication forks and interacts with the replisome to stabilize stalled replication structures. It is recruited to chromatin during S phase and removed after replication completion. The RTF2 antibody supports visualization of these dynamics, allowing researchers to monitor fork progression and resolution under genotoxic stress. RTF2 is critical for preventing aberrant fork degradation and double-strand break formation, thereby maintaining genomic stability.
Loss of RTF2 leads to replication defects, increased DNA damage signaling, and activation of checkpoint kinases such as ATR and CHK1. The RTF2 antibody enables detection of expression changes in response to DNA damage or replication inhibitors, aiding studies into checkpoint control and genome maintenance. Its depletion causes hypersensitivity to replication-blocking agents and reduced cell viability, emphasizing its protective role during S phase.
Replication termination factor 2 also participates in fork restart after hydroxyurea-induced stalling, coordinating reloading of replication machinery components. The RTF2 antibody allows mechanistic studies of this recovery process, revealing how RTF2 collaborates with helicases and nucleases to reestablish replication competence. Dysregulation of RTF2 expression has been implicated in cancer development and progression due to impaired replication fidelity.
The RTF2 antibody performs effectively in western blotting, immunofluorescence, and immunohistochemistry, showing characteristic nuclear staining consistent with its role in DNA metabolism.
Research relevance and current trends
- Connecting protein-level changes to phenotype using orthogonal readouts (genetic perturbation, transcriptomics, imaging).
- Considering isoforms and post-translational regulation when interpreting protein-level changes.
- Comparing results across species and model systems with matched controls.
Common research applications
- Western blotting: compare relative abundance and activation-state changes across conditions.
- Immunofluorescence: visualize subcellular distribution and cell-to-cell heterogeneity.
- Flow cytometry: quantify target-positive populations and signal shifts at single-cell resolution.
- ELISA: support antibody-based quantification in assay formats where applicable.
Interpret changes in signal alongside appropriate controls and, when relevant, in parallel with total-protein or pathway readouts.
Notes for experimental interpretation
- Signal can reflect expression level, isoform composition, and post-translational state; interpret results in the context of your model system and stimuli.
- Species differences and sample matrices can influence epitope recognition; prioritize matched controls and orthogonal confirmation when feasible.
Antibody notes: Polyclonal antibodies recognize multiple epitopes, which can broaden the epitope footprint and may increase sensitivity in some contexts.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
